{"id":"W4403667407","doi":"10.1093/bjd/ljae404","title":"Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Clinical endpoint; Randomized controlled trial; Dupilumab; Adverse effect; Internal medicine; Dermatology; Clinical trial; Dermatology Life Quality Index; Severity of illness; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002975464,0.001312098,0.003414909,0.000389764,0.0005000703,0.001299339,0.0009706953,0.001695043,0.004884852],"category_scores_gemma":[0.002893766,0.0008234112,0.002337598,0.0003230787,0.001021458,0.001407655,0.0004727116,0.00365831,0.0008007109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001147561,"about_ca_system_score_gemma":0.001461669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007557577,"about_ca_topic_score_gemma":0.001934523,"domain_scores_codex":[0.9988112,0.0006384388,0.00009559032,0.0001888763,0.0001013155,0.0001645041],"domain_scores_gemma":[0.9975185,0.0005903653,0.0007132223,0.0001806631,0.0002080312,0.0007892281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9722725,0.01040483,0.00105857,0.0003458299,0.0008552819,0.00002579141,0.00006154695,0.0002505782,0.002513466,0.00003243178,0.0005576615,0.01162138],"study_design_scores_gemma":[0.749407,0.2411281,0.005936534,0.00005190945,0.001097715,0.0000587484,0.00003498599,0.0005456933,0.001079828,0.00008120736,0.0005542709,0.00002417568],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929844,0.002120865,0.0002818951,0.0003029224,0.0001458511,0.002250982,0.0009930728,0.00006318537,0.0008568199],"genre_scores_gemma":[0.9930876,0.001038349,0.0009489214,0.0005203465,0.0001863623,0.00230405,0.0007760461,0.00001678994,0.001121619],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004884852,"threshold_uncertainty_score":0.01634139,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04700225101236575,"score_gpt":0.359323760572684,"score_spread":0.3123215095603182,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}